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Yaws is an ancient primitive disease of man which may have been an African importa-
tion into the New World. It was known to be prevalent (1) in the African slaves of North
Carolina in the early part of the eighteenth century. Today it is essentially a disease of
warm countries and is common in the West Indies, tropical America and Equatorial Africa.
In the Far East it is present in the Malay States, Ceylon, Siam, Netherlands, India, Burma,
French Indo-China and the Philippines as well as the East Indian Islands and other Pacific
Islands, particularly Samoa. It is also prevalent in North Australia, Kenya, Tanganyika
and Uganda.
In Haiti alone, it is estimated that approximately 80 per cent of the rural population is
infected with this disease. The health and economy of the Haitian people is constantly
threatened by a triad of diseases: malaria, hookworm and yaws. Of these, yaws is the
most virulent and the most common and when the disease remains untreated it produces
crippling and a painfully loathsome disfigurement of its victims. Although Haiti is near
the United States, yaws is only rarely encountered in this country (2). Since yaws occurs
primarily in countries that are populated by the colored races, it was for many years sus-
pected that the white race was not susceptible to the disease. It is now known that this is
not correct (3): approximately 18 per cent of 300,000 cases in Brazil and 50 per cent of 500
cases in Cuba occurred among white persons. There has been considerable controversy as
to whether or not yaws is a variant of syphilis. Up to the present time it has not been pos-
sible to distinguish morphologically between the Treponema pertenue and the Treponema
pallida. As the result of the new work by Nelson (4) it may be possible, by means of his
"immobilizing antibody test", to differentiate between these two diseases on an immuno-
logic basis.
Soon after Mahoney, Arnold and Harris (5) demonstrated the efficacy of
penicillin therapy in early syphilis, reports appeared in the literature attesting
to a similar beneficial role in the treatment of yaws (6). The present report deals
with the evaluation of the clinical and serologic results in a series of 1,200
Haitian peasants with early yaws. The patients were selected from five areas:
Port-a-Piment, Belladere, Lascahobas, Pilate and Plaisance. They were all
treated with the same repository penicillin product' on an ambulatory basis
and were divided into three groups:
Group A: Four hundred and fifty patients were treated on a four-day schedule
* From Department of Dermatology and Syphilology, New York University, Medical
School, New York, N.Y. (Dr. Rein), Bristol Laboratories, New York, N.Y. (Dr. Kitchen),
Haitian Yaws Commission, Port-au-Prince, Haiti (Dr. Pétrus). Other members of the
Commission were Doctors Hall, Dambreville, Alcindor and Boulos.
1 The material used for therapy was crystalline sodium penicillin G in peanut oil con-
taining 4.8% beeswax (Romansky formula). The penicillin was supplied in 10 cc. vials,
containing 300,000 units per cc. This entire project was made possible by the generous
sponsorship of Bristol Laboratories, who furnished all materials and expenses attendant
with its execution.
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and received one injection of one cc. of penicillin once a day for a total dose of
1,200,000 Oxford Units.
Group B: Four hundred and ninety-two patients were treated on a two-day
schedule, and received one injection of one cc. twice a day at twelve-hour inter-
vals for a total dose of 1,200,000 Oxford Units.
Group C: Two hundred and fifty-eight patients were treated on a four-day
schedule and received one injection of one cc. twice a day at twelve-hour inter-
vals for a total of 2,400,000 Oxford Units.
Only those patients with early yaws were selected for this study. Whenever
possible, the patients' siblings and parents with tertiary or latent yaws also
received penicillin therapy in order to reduce the incidence of reinfection as
much as possible in the patients chosen for the study. It is estimated that ap-
proximately 2,000 additional patients were thus treated for this purpose and
are not included in this report. All patients, regardless of age or weight, re-
ceived the same amount of therapy in these respective groups.
Prior to the institution of therapy a blood specimen was collected from each
patient and sent to the Central Laboratory of the General Hospital in Port-au-
Prince. Under the direction of George Milfort, each serum was subjected to a
battery of three quantitative tests including the Kahn standard, the Hinton
and V.D.R.L. cardiolipin slide test. Following therapy, the patients were sub-
jected to a clinical and serologic follow-up at approximately three-month inter-
vals for one year. This proved to be the most difficult part of the experiment.
Yaws is most prevalent in the rural areas, and in order to reach a medical clinic
or treatment center, the peasant is obliged to travel on foot for many miles over
mountains and bad roads, which are often completely blocked during the rainy
season. If his disease is severe enough, he will somehow manage to reach a
clinic for therapy. After the clinical aspects of the disease have disappeared, he
does not see the necessity for serologic rechecks. It, therefore, became necessary
to seek the treated individuals for the three-month follow-up and it often re-
quired several days of difficult traveling to find one patient. In order to assist
in encouraging the patients to return for clinical and serologic follow-up ex-
aminations, many of them were paid at the rate of ten cents in gold for this
cooperation.
Table I presents data showing the total number of patients initially treated
in each of Groups A, B and C and the number of each group followed success-
fully for a period of one year. It is interesting to note that in spite of the diffi-
culties, 787 were examined clinically and serologically at the end of the twelve-
month period for a follow-up of 65.6%.
In order to evaluate the serologic results obtained in these cases in a twelve-
month follow-up period, the following arbitrary criteria and definitions were
accepted:
Serologic Cure—This denoted seronegativity attained and maintained follow-
ing treatment.
Serologic Improvement—This constituted a reduction in serologic titer, in-
dicating a satisfactory serologic response, but seronegativity not attained.
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Serologic Fastness—This indicated failure to show a reduction in serologic
titer below the pretreatment level.
Serologic Relapse—This constituted an initial reduction in serologic titer
followed by a sudden and progressive increase in titer, indicating an unsatis-
factory response to penicillin therapy, serologic failure of this treatment, or an
asymptomatic reinfection.
In this study, the results reported are limited to those obtained with the
Kahn standard and quantitative tests. This is done in order to facilitate corn-
TABLE I
GROUP TREATED FOLLOwED'
312
314
161
PERCENT
69.3
63.7
62.4
A
B
C
450
492
258
Total 1,200 787 65.6
* Minimum period of 12 months.
TABLE II
GROUPS
A
B
C
SEROLOGIC CURE
115
(36.86%)
122
(38.85%)
79
(49.06%)
SEROLOGIC I-
PROVE(ENT
173
(55.44%)
163
(51.91%)
73
(45.34%)
SEROLOGIC FAST-
NESS
21
26
8
PLUS
(7.69%)
(9.23%)
(5.59%)
SEROLOGIC RELAPSI
3
3
1
Serologic cure and serologic improvement
GROUPS
A
B
C
92.30%
90.76%
94.40%
parison of our results with those of other investigators, since the majority of
publications pertaining to treatment of yaws are based on serologic results ob-
tained with Kahn tests. Furthermore, in the majority of reports dealing with
penicillin therapy in syphiiis, the Kahn test is also employed as a serologic meas-
urement. It should be pointed out that the evaluation of our results would be
somewhat different if it had been based on reactions to more sensitive tests.
The serologic pattern and the degree of serologic improvement evidenced by
the reactions to the various tests were, however, similar with all three pro-
cedures.
Table II records numerical data showing the number of patients in each of
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the three groups who were serologically cured, serologically improved, sero-
logically fast or serologically relapsed at the end of one year. By our previous
definition of serologic cure and improvement, it will be seen that even with
the most unfavorable results which occurred in Schedule B, a 90.76% serologic
cure and improvement rate was obtained. The best results were obtained in
Group C with 94.40% of the patients in this classification. With identical total
dosage, the four-day schedule was more effective than the two-day schedule
and with identical total duration of therapy, 2.4 million units seemed more
effective than 1.2 million units.
It is to be expected that there will be more "serologic cures" during the
second and perhaps the third year of follow-up serologic examinations.
From the clinical point of view, the results were rapid and with the second
injection the patient felt much better; headaches and joint pains had disappeared.
Plantar and palmar "crab" lesions became painless by the fourth day. Primary
and secondary lesions were in the desiccation stage in four days, at which time
the crusts could be easily removed, revealing a dry and well-healed underlying
TABLE III
Clinical re8ults
CUkD
95%
IMPROVED
3%
NO CAGE
2%*Group A
Group B 94% 4% 2%
Group C 98% 0 2%*
* There remains some doubt as to the correctness of the diagnosis of these few patients.
There were no proven instances of either clinical reinfection or relapse in the patients
followed for one year.
skin. Complete healing of all lesions was observed in most instances on the
first re-examination three months following completion of therapy.
Table III presents data concerned entirely with the clinical results at the
end of the one-year study period. The extremely high cure and improvement
rate and the extremely low percentage of patients exhibiting no change clinically
is characteristic of the clinical response to this type of treatment.
DISCUSSION
Penicillin in an absorption-delaying menstruum is of utmost value in countries
such as Haiti, where the majority of patients must be treated in the shortest
period of time and on an ambulatory basis in rural clinics. It is impossible to
hospitalize the patients because of lack of necessary facilities, nor is it possible
to accommodate them at out-patient clinics for more than three or four days.
The newer procaine penicillin in oil with aluminum monostearate2 has largely
replaced the older penicillin in oil with beeswax used in this study and will
possibly be highly effective in doses of 4 cc. given in a single injection (7). Such
'Flo-Cillin "96" (Bristol Laboratories).
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a schedule is now being utilized by us in the Republic of Mexico in a large study
of the effectiveness of this product in the treatment of pinta. Over 800 patients
have been observed for nine months following the administration of this new
preparation in various schedules and the results will be reported following a
suitable post-treatment observation period.
Recent investigations (8) with this preparation in early syphilis indicate that
a single injection of one to four cubic centimeters will be effective in more than
90 per cent of patients treated. Similar excellent results are anticipated with
single injections in early yaws and pinta.
From our data it is evident that the clinical response of early yaws to peni-
cillin therapy is uniformly and invariably excellent. The rapid and complete
healing of lesions is dramatic. The serologic response, however, is much slower
and less satisfactory than that observed in the treatment of early syphilis with
similar treatment schedules. A higher percentage of serologic cures was obtained
in this study employing crystalline sodium G penicillin in peanut oil and beeswax
than in the previous study (6m) employing sodium penicillin in aqueous solution
and amorphous calcium penicillin in peanut oil and beeswax.
CONCLUSIONS
Based on clinical response, repository penicillin is the drug of choice in the
present day treatment of yaws. Penicillin in an absorption-delaying menstruum
is of great value in countries such as Haiti where the majority of the patients
must be treated in the shortest period of time and on an ambulatory basis in
rural clinics.
The clinical results obtained with penicillin were consistently and invariably
good. They were definitely better and were obtained more rapidly with penicillin
than with the previously employed arsenic and bismuth therapy. Furthermore,
with penicillin, a maximum amount of therapy could be administered in a
minimum period of time without any fear of serious untoward reactions. Al-
though the majority of patients (92.1 per cent) showed satisfactory serologic
progress, only 316 (40.6 per cent) had attained seronegativity at the end of a
twelve-month follow-up period.
Since the cause of yaws is known and since a simple and safe form of therapy
is available, it is now possible to "cure" yaws in a short period of treatment time
at a low cost. There is no reason for 80 per cent of the rural population of Haiti
to be affected with this crippling and disfiguring non-venereal treponemal dis-
ease.
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DISCUSSION
DR. THOMAS H. STERNBERG: I was anxious to discuss this paper mainly be-
cause in 1944 Dr. Rein and I, together with Dr. Dwindle, conducted a rather
extensive study of the effects of penicillin in yaws, in Haiti. Our experience at
that time was of considerable value to the present authors in setting up their
experiment. It is almost impossible to believe the prevalence of this disease in
Haiti. Some 80% of the natives have yaws. On our first visit to a yaws' clinic
in one of the rural areas outside of Port-au-Prince, there were actually hundreds
of people camped around the clinic in the most unhygienic conditions with
every conceivable type of yaws—an almost unbelievable situation. This present
report establishes what our preliminary investigations indicated, namely, that
the spirochete of yaws responds to penicillin in an identical manner to the
spirochete of syphilis.
In my opinion, the important aspect of this report and the preceding ones
are their public health significance. A single injection of penicillin in oil resulted
in a clinical "cure", with complete disappearance of the lesions in almost every
case. There were very few infectious relapses. Since yaws is spread through
contact, and is non-venereal in origin, this is of considerable importance from
the public health point of view. With a small amount of money, a few inter-
ested people, and portable equipment, yaws could be pretty well eradicated in
Haiti in a relatively short period of time.
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DR. CHARLES R. REIN: In addition to the 1200 patients reported on by Dr.
Kitchen, we treated 2000 parents and siblings who were also infected. Therefore
some 3200 patients with yaws were treated in this particular study. The sero-
logic results appear to be better than those obtained in our preliminary studies
with Doctors Sternberg, Dwinelle and Sheldon. Our follow-up rate was excep-
tionally good through the efforts of Dr. Pétrus who often travelled several
days on horseback to find one patient for a clinical and serologic recheck. Fur-
thermore, we paid the patients a small amount of money to encourage them to
return at three-month intervals for rechecks and this helped a great deal.
At the present time we are carrying out a similar study on penicillin therapy
of pinta in Mexico. Preliminary results seem to indicate that a single injection
of 4 cc. of procaine penicillin in oil and aluminum monostearate will prove
successful. Untoward reactions with this newer preparation are considerably
less frequent than with the older P.O.B. material. If these short one-day sched-
ules prove effective, the World Health Organization will be ready for world-
wide eradication of these treponemal diseases.
